Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma

BACKGROUND: Recent experience with thalidomide maintenance after high-dose chemotherapy with autologous stem cell support has demonstrated improvement in progression-free and overall survival. We further explored the tolerability and efficacy of lower doses of maintenance thalidomide in this single...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chang, Julie E., Juckett, Mark B., Callander, Natalie S., Kahl, Brad S., Gangnon, Ronald E., Mitchell, Teri L., Longo, Walter L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2913594/
https://ncbi.nlm.nih.gov/pubmed/18650178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CLM.2008.n.018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados